Cenci, Tonia
 Distribuzione geografica
Continente #
EU - Europa 2.899
NA - Nord America 2.862
AS - Asia 1.015
AF - Africa 14
SA - Sud America 5
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 4
Totale 6.803
Nazione #
US - Stati Uniti d'America 2.849
DE - Germania 1.316
CN - Cina 745
SE - Svezia 497
IT - Italia 248
UA - Ucraina 218
IE - Irlanda 133
SG - Singapore 122
GB - Regno Unito 111
FR - Francia 108
PL - Polonia 94
FI - Finlandia 63
RU - Federazione Russa 52
TR - Turchia 49
IN - India 46
BE - Belgio 17
CI - Costa d'Avorio 13
IR - Iran 12
JP - Giappone 12
HK - Hong Kong 9
NL - Olanda 9
VN - Vietnam 9
CA - Canada 8
CH - Svizzera 7
AT - Austria 6
ES - Italia 5
EU - Europa 4
MX - Messico 4
RO - Romania 4
AU - Australia 3
KR - Corea 3
BR - Brasile 2
CZ - Repubblica Ceca 2
LK - Sri Lanka 2
MD - Moldavia 2
NO - Norvegia 2
SA - Arabia Saudita 2
TW - Taiwan 2
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
CL - Cile 1
CM - Camerun 1
EC - Ecuador 1
GR - Grecia 1
IL - Israele 1
KW - Kuwait 1
LV - Lettonia 1
NZ - Nuova Zelanda 1
PA - Panama 1
PE - Perù 1
RS - Serbia 1
Totale 6.803
Città #
Ashburn 625
Chandler 513
Hangzhou 313
Jacksonville 140
Dublin 133
San Mateo 110
Nanjing 104
Nürnberg 98
Ann Arbor 89
Beijing 88
Singapore 88
Wilmington 84
Warsaw 82
Woodbridge 74
New York 65
Dearborn 64
Houston 64
Fairfield 57
Cattolica 49
Seattle 49
Izmir 48
Nanchang 42
Boston 39
Moscow 38
Lawrence 37
Milan 36
Los Angeles 33
Princeton 33
Bremen 31
Redwood City 31
Rome 30
Kunming 29
Munich 25
Redmond 25
Marseille 24
Chicago 22
Lancaster 21
Mountain View 20
Shenyang 20
Helsinki 19
Hebei 17
Cambridge 15
Brussels 14
Jiaxing 14
Norwalk 14
Abidjan 13
Leawood 12
Tianjin 12
Boardman 11
Kraków 11
Changsha 9
Fremont 9
Shanghai 9
University Park 9
Zhengzhou 9
Auburn Hills 8
Guangzhou 8
Augusta 7
Berlin 7
Hefei 7
Jinan 7
Naples 7
Pune 7
Detroit 6
Edinburgh 6
Hong Kong 6
Verona 6
Vienna 6
Dong Ket 5
Gunzenhausen 5
Lanzhou 5
Simi Valley 5
Bern 4
Changchun 4
Indiana 4
Ladispoli 4
Mumbai 4
Orange 4
Pomigliano d'Arco 4
San Diego 4
Stockholm 4
Washington 4
Andover 3
Falls Church 3
Florence 3
Frankfurt am Main 3
Hanoi 3
Islington 3
Kish 3
London 3
Madrid 3
Mcallen 3
Monmouth Junction 3
Northbrook 3
Padova 3
Palermo 3
Paris 3
Phoenix 3
Renton 3
Seoul 3
Totale 3.872
Nome #
Discordance of KRAS Mutational Status between Primary Tumors and Liver Metastases in Colorectal Cancer: Impact on Long-Term Survival Following Radical Resection 506
Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells 442
Diagnostic and prognostic role of HBME-1, galectin-3, and β-catenin in poorly differentiated and anaplastic thyroid carcinomas 362
Is there a role for IGF1R and c-MET pathways in resistance to cetuximab in metastatic colorectal cancer? 248
Preferential MGMT methylation could predispose a subset of KIT/PDGFRA-WT GISTs, including SDH-deficient ones, to respond to alkylating agents 204
C-myc expression is a possible keystone in the colorectal cancer resistance to egfr inhibitors 195
KRAS mutational status affects oxaliplatin-based chemotherapy independently from basal mRNA ERCC-1 expression in metastatic colorectal cancer patients 179
Von hippel-lindau disease and erythrocytosis 147
Analysis of immunocytochemical and molecular BRAF expression in thyroid carcinomas: A cytohistologic institutional experience 144
Diagnostic and prognostic value of immunocytochemistry and braf mutation analysis on liquid based biopsies of thyroid neoplasms suspicious for carcinoma. 136
The viral load of Epstein-Barr virus (EBV) DNA in peripheral blood predicts for biological and clinical characteristics in Hodgkin lymphoma 132
Different STAT-3 and STAT-5 phosphorylation discriminates among Ph-negative chronic myeloproliferative diseases and is independent of the V617F JAK-2 mutation. 128
PDGFRA-mutant syndrome 127
The viral load of Epstein-Barr virus (EBV) DNA in peripheral blood predicts for biological and clinical characteristics in Hodgkin lymphoma 124
Case of Rectal GI Stromal Tumor Demonstrating that KIT and PDGFRA Mutations Are Not Always Mutually Exclusive 124
c-MYC Expression Is a Possible Keystone in the Colorectal Cancer Resistance to EGFR Inhibitors. 118
Phosphorylated STAT5 represents a new possible prognostic marker in Hodgkin lymphoma. 108
KRAS Exon 2 Mutations as Prognostic Indicators in Advanced Colorectal Cancer in Clinical Practice: A Mono-Institutional Study 104
Epigenetic silencing of SOCS3 identifies a subset of prostate cancer with an aggressive behavior 102
Epigenetic silencing of Id4 identifies a glioblastoma subgroup with a better prognosis as a consequence of an inhibition of angiogenesis. 98
Expression of EGFRvIII in glioblastoma: prognostic significance revisited. 97
The revised WHO diagnostic criteria for Ph-negative myeloproliferative diseases are not appropriate for the diagnostic screening of childhood polycythemia vera and essential thrombocythemia 95
Circulating hematopoietic stem cells and putative intestinal stem cells in coeliac disease 94
Hereditary thrombocytosis caused by MPLSer505Asn is associated with a high thrombotic risk, splenomegaly and progression to bone marrow fibrosis 93
The mutant JAK2 allele burden in children with essential thrombocythemia 86
Chemotherapy of skull base chordoma tailored on responsiveness of patient-derived tumor cells to rapamycin 85
Endothelial progenitor cells are clonal and exhibit the JAK2(V617F) mutation in a subset of thrombotic patients with Ph-negative myeloproliferative neoplasms 84
The viral load of Epstein-Barr virus (EBV) DNA in peripheral blood predicts for biological and clinical characteristics in Hodgkin lymphoma 80
Endothelial progenitor cells are clonal and exhibit the JAK2(V617F) mutation in a subset of thrombotic patients with Ph-negative myeloproliferative neoplasms 80
Epigenetic silencing of SOCS3 identifies a subset of prostate cancer with an aggressive behavior 79
Epigenetic alteration of SOCS family members is a possible pathogenetic mechanism in JAK2 wild type myeloproliferative diseases 79
Uncommon BRAF mutations in the follicular variant of thyroid papillary carcinoma: New insights 79
A novel heterozygous HIF2AM535I mutation reinforces the role of oxygen sensing pathway disturbances in the pathogenesis of familial erythrocytosis 76
Thrombopoietin receptor activation, thrombopoietin mimetic drugs, and hereditary thrombocytosis: remarks on bone marrow fibrosis 75
The evaluation of miRNAs on thyroid FNAC: the promising role of miR-375 in follicular neoplasms 74
Prognostic relevance of c-Myc and BMI1 expression in patients with glioblastoma 72
The clinical value of patient-derived glioblastoma tumorspheres in predicting treatment response 71
Phosphorylated STAT5 represents a new possible prognostic marker in Hodgkin lymphoma 70
Preferential MGMT methylation could predispose a subset of KIT/PDGFRA-WT GISTs, including SDH-deficient ones, to respond to alkylating agents 69
Eight-year survival of a recurrent glioblastoma patient treated with molecularly tailored therapy: a case report 62
The bladder epicheck test and cytology in the follow-up of patients with non-muscle-invasive high grade bladder carcinoma 62
Markers of myeloproliferative diseases in childhood polycythemia vera and essential thrombocythemia 61
Chemotherapy of Skull Base Chordoma Tailored on Responsiveness of Patient-Derived Tumor Cells to Rapamycin1,2 61
Plexiform architecture in gastrointestinal stromal tumors is not restricted to succinate dehydrogenase-deficient cases 61
A phase 2 study of temozolomide in pretreated metastatic colorectal cancer with MGMT promoter methylation 61
Prognostic relevance of SOCS3 hypermethylation in patients with glioblastoma multiforme 59
Divergent gastrointestinal stromal tumors in syndromic settings 59
Characterization of variants in the promoter of EBV gene BZLF1 in normal donors, HIV-positive patients and in AIDS-related lymphomas 53
Methylation study of the Paris system for reporting urinary (TPS) categories 53
Tailored therapy for recurrent glioblastoma. Report of a personalized molecular approach 53
Morphology combined with ancillary techniques: An algorithm approach for thyroid nodules 52
how limited molecular testing can also offer diagnostic and prognostic evaluation of thyroid nodules processed with liquid based cytology. Role of TERT promoter and BRAF V600E mutation analysis 51
The combination cytology/epichek test in non muscle invasive bladder carcinoma follow-up: Effective tool or useless expence? 48
Pituitary-tumour-transforming-gene 1 expression in testicular cancer 47
Expression of the stem cell marker CD133 in recurrent glioblastoma and its value for prognosis 46
SOCS3 Immunohistochemical Expression Seems to Support the 2005 and 2014 International Society of Urological Pathology (ISUP) Modified Gleason Grading System 46
Morphology combined with ancillary techniques: An algorithm approach for thyroid nodules 45
Epigenetic Silencing of Id4 Identifies a Glioblastoma Subgroup With a Better Prognosis as a Consequence of an Inhibition of Angiogenesis 44
Protein Expression of PTTG-1, OCT-4, and KLF-4 in Seminoma: A Pilot Study. 44
Clinical and NGS predictors of response to regorafenib in recurrent glioblastoma 43
To obtain more with less cytologic samples with ancillary molecular techniques-the useful role of liquid-based cytology 43
The clinical value of patient-derived glioblastoma tumorspheres in predicting treatment response 41
The clinical value of patient-derived glioblastoma tumorspheres in predicting treatment response 39
Case of Rectal GI Stromal Tumor Demonstrating that KIT and PDGFRA Mutations Are Not Always Mutually Exclusive 38
Epigenetic silencing of Id4 identifies a glioblastoma subgroup with a better prognosis as a consequence of an inhibition of angiogenesis 37
The role of thyroid FNA cytology in pediatric malignant lesions: An overview of the literature 34
Expression of the stem cell marker CD133 in recurrent glioblastoma and its value for prognosis 33
Chemotherapy of skull base chordoma tailored on responsiveness of patient-derived tumor cells to rapamycin 32
Erratum: Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells (Nature (2010) 468 (824-828)) 31
The Immunohistochemical Analysis of SOCS3 Protein Identifies a Subgroup of Prostatic Cancer Biopsies with Aggressive Behavior 31
DNA methylation analysis in urinary samples: A useful method to predict the risk of neoplastic recurrence in patients with urothelial carcinoma of the bladder in the high-risk group 29
The Immunohistochemical Analysis of SOCS3 Protein Identifies a Subgroup of Prostatic Cancer Biopsies With Aggressive Behavior 28
PTTG1/ZEB1 Axis Regulates E-Cadherin Expression in Human Seminoma 27
Telomerase inhibition in malignant gliomas. A systematic review 24
Dissecting Stemness in Aggressive Intracranial Meningiomas: Prognostic Role of SOX2 Expression 21
Upper urothelial tract high-grade carcinoma: comparison of urine cytology and DNA methylation analysis in urinary samples. 19
SPTBN1 Mediates the Cytoplasmic Constraint of PTTG1, Impairing Its Oncogenic Activity in Human Seminoma 10
Paths of Evolution of Progressive Anaplastic Meningiomas: A Clinical and Molecular Pathology Study 4
Totale 6.898
Categoria #
all - tutte 24.714
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.714


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020781 0 0 69 43 75 86 127 55 83 47 117 79
2020/2021642 48 101 53 56 76 43 53 7 74 26 91 14
2021/2022679 73 44 18 65 58 20 16 97 28 48 90 122
2022/20231.388 203 205 105 217 93 164 56 87 162 28 48 20
2023/20241.129 27 210 25 50 16 95 265 261 6 30 68 76
2024/202596 34 30 32 0 0 0 0 0 0 0 0 0
Totale 6.898